an insight into the changing role of transplantation for myeloma & lymphoma in the era of car-t
Published 1 month ago • 74 plays • Length 4:21Download video MP4
Download video MP3
Similar videos
-
1:04
the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
2:30
an update on the current status of car-t therapy in multiple myeloma
-
3:07
the role of bridging and timing in car-t
-
9:25
mgus diagnosis: a step-by-step approach
-
40:33
open mics with dr. stites: “miraculous” new treatment for multiple myeloma
-
35:10
mtor signaling in growth and metabolism
-
2:39
a look into the future of multiple myeloma treatment: t-cell redirecting therapies vs autohsct
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
1:00:19
the molecular twin platform: a multi-omic approach for predicting accurate clinical outcomes
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
1:59
the role of upfront double auto-sct in high-risk myeloma
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
1:39
paradigm-changing car t-cell therapy for multiple myeloma
-
1:53
the future of multiple myeloma treatment
-
0:58
novel car-t constructs emerging in multiple myeloma for patients who experience loss of bcma
-
3:56
considerations and challenges of integrating car-t and transplantation in b-all
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
0:41
mechanism of action of the tri-specific t-cell activating construct hpn217 in r/r multiple myeloma
-
1:37
mrd in myeloma
-
4:03
novel technologies in multiple myeloma and how these are changing the field